Physician profile
David C Stout
NPI 1396854899
$1,004.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $82.19 · 2021: $79.04 · 2022: $58.83 · 2024: $18.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $206.72 | 2019-2022 | |
| Janssen Biotech, INC. | $128.61 | 2019-2022 | |
| Coloplast Corp | $120.62 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $63.74 | 2019-2020 | |
| Blue Earth Diagnostics | $59.76 | 2019 | |
| Dendreon Pharmaceuticals LLC | $55.50 | 2019 | |
| Allergan, INC. | $55.39 | 2019 | |
| Cook Medical LLC | $54.00 | 2019-2021 | |
| Pfizer INC. | $52.27 | 2019 | |
| Amgen INC. | $52.24 | 2019 | |
| Myriad Genetic Laboratories, INC. | $40.38 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.37 | 2019 | |
| Rochester Medical Corporation | $24.26 | 2019 | |
| Siemens Medical Solutions USA, INC. | $18.43 | 2024 | Magnetom Sola |
| Endo Pharmaceuticals INC. | $17.11 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.81 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.